Structure and properties of hydroxyapatite/hydroxyethyl cellulose acetate composite films.

The main aim of this research work was to develop a new inorganic-organic film. Hydroxyapaptite (HAp) particles that represent the inorganic phase was mixed well with hydroxyethyl cellulose acetate (HECA), which representing the organic phase and then the inorganic-organic films were fabricated by evaporating of the solvent. The structure as well as the properties of the formed films were characterized using different analytical tools such as field emission scanning electron microscopy (FEG-SEM), thermo-gravimetric analysis (TGA), Fourier transform infra-red (FT-IR) spectroscopy. The obtained results revealed that, the HAp nanoparticles was well dispersed and well immobilized throughout the formed films. This can be attributed to the role of the nano- and micropores in the HECA substrate. In addition, a strong interaction occurred between HAp and HECA matrix. The results showed also good thermal stability and miscibility as well.

[Medicines and breastfeeding: assessing the risk of medicines to infants]. / Médicaments et allaitement maternel: evaluation du risque médicamenteux chez le nourrisson.

Milk, in addition to its undeniable nutritional and immunological benefits, is an important element for the development of the infant. Warnings, sometimes exaggerated, may prevent the mother and child from enjoying the benefits of both breastfeeding and appropriate medication. This approach is justified by the total absence of investigations on the excretion of drugs in breast milk during clinical trials. The actual risk was evaluated by several classifications; an estimate of the passage of drugs into milk and estimation of infant exposure to the drug are possible and can provide a reliable indicator to better judge the risk to the infant. Generally we are faced with two different situations: a new treatment during lactation or maintenance treatment already prescribed during pregnancy. If treatment needs to be prescribed for a long period of breastfeeding, a strategic approach is required.

Medicines and breastfeeding: assessing the risk of medicines to infants

Milk, in addition to its undeniable nutritional and immunological benefits, is an important element for the development of the infant. Warnings, sometimes exaggerated, may prevent the mother and child from enjoying the benefits of both breastfeeding and appropriate medication. This approach is justified by the total absence of investigations on the excretion of drugs in breast milk during clinical trials. The actual risk was evaluated by several classifications; an estimate of the passage of drugs into milk and estimation of infant exposure to the drug are possible and can provide a reliable indicator to better judge the risk to the infant generally we are faced with two different situations: a new treatment during lactation or maintenance treatment already prescribed during pregnancy. If treatment needs to be prescribed for a long period of breastfeeding, a strategic approach is required